Cholesteryl hemisuccinate treatment protects rodents from the toxic effects of acetaminophen, adriamycin, carbon tetrachloride, chloroform and galactosamine
| Autor: | Marc W. Fariss, Sidhartha D. Ray, H.Robert Lippman, Virgil R. Mumaw |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Tris
Male Programmed cell death Heart Diseases CCL4 Galactosamine Toxicology Rats Sprague-Dawley chemistry.chemical_compound Mice medicine Animals Carbon Tetrachloride Acetaminophen Mice Inbred ICR Chemistry Liver Diseases General Medicine Cytoprotection Rats Biochemistry Doxorubicin Toxicity Carbon tetrachloride Chloroform Cholesterol Esters Chemical and Drug Induced Liver Injury medicine.drug |
| Zdroj: | Toxicology letters. 90(2-3) |
| ISSN: | 0378-4274 |
| Popis: | In addition to its use as a stabilizer/rigidifier of membranes, cholesteryl hemisuccinate, tris salt (CS) administration has also been shown to protect rats from the hepatotoxic effects of carbon tetrachloride (CCl4). To further our understanding of the mechanism of CS cytoprotection, we examined in rats and mice the protective abilities of CS and the non-hydrolyzable ether form of CS, gamma-cholesteryloxybutyric acid, tris salt (CSE) against acetaminophen-, adriamycin-, carbon tetrachloride-, chloroform- and galactosamine-induced toxicity. The results of these studies demonstrated that CS-mediated protection is not selective for a particular species, organ system or toxic chemical. A 24-h pretreatment of both rats and mice with a single dose of CS (100mg/kg, i.p.), resulted in significant protection against the hepatotoxic effects of CCl4, CHCl3, acetaminophen and galactosamine and against the lethal (and presumably cardiotoxic) effect of adriamycin administration. Maximal CS-mediated protection was observed in experimental animals pretreated 24 h prior to the toxic insult. These data suggest that CS intervenes in a critical cellular event that is an important common pathway to toxic cell death. The mechanism of CS protection does not appear to be dependent on the inhibition of chemical bioactivation to a toxic reactive intermediate (in light of the protection observed against galactosamine hepatotoxicity). However, based on the data presented, we can not exclude the possibility that CS administration inhibits chemical bioactivation. Our findings do suggest that CS-mediated protection is dependent on the action of the intact anionic CS molecule (non-hydrolyzable CSE was as protective as CS), whose mechanism has yet to be defined. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect